Dendrimers are a highly adaptable and promising family of next-generation nanocarriers with great potential for precise drug delivery and improved therapeutic applications, and continued efforts toward developing safer and biodegradable dendrimer architectures are imperative to facilitate their successful integration i...
Abdul Shadab, Abdul Faiz Ansari, Osama Y. Alshogran· Current Nanomedicine· 0 citations
This paper presents a comprehensive review of recent advances in lipid-based nanocarrier-mediated combination therapies in breast cancer treatment, highlighting the need for developing more effective and specific strategies to address the mentioned obstacles.
Abdul Shadab, Md. Faheem Haider, Mohammad Abohassan· Naunyn-Schmiedeberg's Archiv...· 0 citations
KEAP1-Nrf2 represents a context-dependent therapeutic axis with substantial potential across chronic inflammatory diseases and integrating quantitative evidence, precision delivery, biomarker-guided approaches, and computational strategies may facilitate clinical translation while addressing risks associated with susta...
Abdul Shadab· Immunological Investigations· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.